Abstract:Background: Upper and lower airways diseases share in part their pathogenic mechanisms and frequently occur simultaneously as "United Airway Disease." Local treatment with nebulizers delivers anti-symptomatic drugs in either the upper or the lower airways, according to the particle size generated by the nebulizer. To our knowledge, no nebulizer combines both application ways. The aim of this study is to test the efficacy and usability of a new nebulizer (OMRON A3 complete), generating aerosols with particles diameters of 2-4.5 μm, 4.5-7.5 μm or >7.5 μm, according to the user's choice. Methods: Seventy-seven patients between 5 and 17 years of age with a diagnosis of rhinitis or asthma were examined. Oxymetazoline or Salbutamol were prescribed according to best clinical practice guidelines. Both drugs were administered through the OMRON A3 Complete nebulizer, with a particle dimension of >7.5 μm to treat nasal obstruction and 2-4.5 μm for bronchial obstruction. The efficacy of treatment was assessed by total nasal inspiratory airflow and FEV-1, Tiffeneau index (FEV1/FVC) and MMEF 25/75 respectively, 10 min before and after treatment. Symptom improvement and usability were measured by patients' and doctors' questionnaires. Results: Overall, 77 patients seeking care for acute respiratory symptoms were assigned to the upper (n = 39) or lower (n = 38) airways disease group. For symptoms of the upper airways, 92% (95% CI, 77-97%) of the patients reported subjective improvement, while 87% (95% CI, 73-94%) did so for the lower airways. The average total nasal inspiratory airflow improved significantly (p = 0.030) among the patients with upper airways symptoms, from 275 ml/s (95% CI, 207-342 ml/s) to 359 ml/s (95% CI, 300-419 ml/s) after Oxymetazoline administration. All selected lung function parameters (FEV1, Tiffeneau Index and MMEF25-75) significantly improved among the patients with lower airways symptoms after inhalation of Salbutamol (p < 0.001). The nebulizer was assessed as "easy to use" by over 95% of participants in both groups. Conclusions: The OMRON A3 efficiently delivers anti-symptomatic drugs in both upper and lower airways in a user-friendly way. This device may be useful to facilitate adherence to a complete treatment of respiratory symptoms in patients with symptoms of the so-called United Airway Disease.

How Does Oxymetazoline Change Nasal Aerodynamics and Symptomatology in Patients with Turbinate Hypertrophy?

Oxymetazoline nasal spray in treatment of obstructive sleep apnea-hypopnea syndrome with nasal obstruction

The effect of inferior turbinate hypertrophy on nasal spray distribution to the middle meatus

[Nasal Coblation Plasma Surgery for the Treatment of Persistent Allergic Rhinitis: an Evaluation of Short-Term Outcomes].

Oxymetazoline nasal spray improved nCPAP compliance in obstructive sleep apnea-hypopnea syndrome patients with nasal obstruction

A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold

Impact of Middle Turbinectomy on Airflow to the Olfactory Cleft: A Computational Fluid Dynamics Study

Comparing Sinonasal Quality of Life in Pediatric Nasal Obstruction: Inferior Turbinate Cauterization vs Turbinoplasty – A Pilot Study

A Preliminary Report on the Correlation Between Nasal Function and the Different Phases of the Nasal Cycle.

Efficacy and usability of a novel nebulizer targeting both upper and lower airways

The clinical efficacy of nasal endoscope surgery for patients with chronic hypertrophic rhinitis and the related factors for the postoperative olfactory recovery

Rhinitis medicamentosa – comparing two treatment strategies: a retrospective analysis

[A Computational Fluid Dynamics Study of Inner Flow Through Nasal Cavity with Unilateral Hypertrophic Inferior Turbinate].

[Radiofrequency Ablation for Treatment of Nasal Obstruction Secondary to Inferior Turbinate Hypertrophy].

Computational Fluid Dynamics (CFD) Investigation of Aerodynamic Characters Inside Nasal Cavity Towards Surgical Treatments for Secondary Atrophic Rhinitis

Exploring the Relationships Between Clinical Examination Findings, Subjective Reported Symptoms and Objective Nasal Patency Measures in Nasal Obstruction: A Baseline NAIROS Sub-Study Analysis

Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction

Study of Inferior Turbinate Reconstruction with Medpor for the Treatment of Empty Nose Syndrome

Nasal Obstruction: Overview of Pathophysiology and Presentation of a Clinically Relevant Preoperative Plan for Rhino(Septo)plasty

A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone

Computational analysis of nasal airflow and its alteration by a nasal dilator